As of 2024-07-27, the EV/EBITDA ratio of Flexion Therapeutics Inc (FLXN) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLXN's latest enterprise value is 564.21 mil USD. FLXN's TTM EBITDA according to its financial statements is -78.25 mil USD. Dividing these 2 quantities gives us the above FLXN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 16.0x | 12.4x |
| Forward P/E multiples | 15.7x - 20.9x | 18.2x |
| Fair Price | (27.17) - (27.58) | (26.54) |
| Upside | -397.9% - -402.4% | -391.0% |
| Date | EV/EBITDA |